Search Results

You are looking at 51 - 60 of 198 items for :

  • Risk of malignancy x
Clear All
Rony Ruben Department of Endocrinology, Amrita Institute of Medical Sciences, Kochi, India

Search for other papers by Rony Ruben in
Google Scholar
PubMed
Close
,
Praveen V. Pavithran Department of Endocrinology, Amrita Institute of Medical Sciences, Kochi, India

Search for other papers by Praveen V. Pavithran in
Google Scholar
PubMed
Close
,
V. Usha Menon Department of Endocrinology, Amrita Institute of Medical Sciences, Kochi, India

Search for other papers by V. Usha Menon in
Google Scholar
PubMed
Close
,
Vasantha Nair Department of Endocrinology, Amrita Institute of Medical Sciences, Kochi, India

Search for other papers by Vasantha Nair in
Google Scholar
PubMed
Close
, and
Harish Kumar Department of Endocrinology, Amrita Institute of Medical Sciences, Kochi, India

Search for other papers by Harish Kumar in
Google Scholar
PubMed
Close

necessary to predict the risk of persistence or recurrence of disease after initial therapy seen in about 12–29% [ 3 , 4 ]. In 1996, the American Thyroid Association (ATA) published treatment guidelines for patients with thyroid nodules and DTC [ 5

Free access
Jiahui Wu Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Jiahui Wu in
Google Scholar
PubMed
Close
,
Xunyang Hu Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Xunyang Hu in
Google Scholar
PubMed
Close
,
Paula Seal EFW Radiology, Calgary, Alberta, Canada
Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Paula Seal in
Google Scholar
PubMed
Close
,
Parthiv Amin Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Parthiv Amin in
Google Scholar
PubMed
Close
,
Brendan Diederichs Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Mayfair Radiology, Calgary, Alberta, Canada

Search for other papers by Brendan Diederichs in
Google Scholar
PubMed
Close
, and
Ralf Paschke Section of Endocrinology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Departments of Medicine, Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology, and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Ralf Paschke in
Google Scholar
PubMed
Close

. IRG implemented a predetermined list of terms in a dropdown menu and required fields for each nodule characteristic and the malignancy risk classification. The purpose of these changes was to standardize and accelerate the reporting process in

Open access
Nicholas S. Andresen Department of Radiation Oncology, University of Iowa, Iowa City, Iowa, USA

Search for other papers by Nicholas S. Andresen in
Google Scholar
PubMed
Close
,
John M. Buatti Department of Radiation Oncology, University of Iowa, Iowa City, Iowa, USA

Search for other papers by John M. Buatti in
Google Scholar
PubMed
Close
,
Hamed H. Tewfik Iowa City Cancer Treatment Center, Iowa City, Iowa, USA

Search for other papers by Hamed H. Tewfik in
Google Scholar
PubMed
Close
,
Nitin A. Pagedar Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, Iowa, USA

Search for other papers by Nitin A. Pagedar in
Google Scholar
PubMed
Close
,
Carryn M. Anderson Department of Radiation Oncology, University of Iowa, Iowa City, Iowa, USA

Search for other papers by Carryn M. Anderson in
Google Scholar
PubMed
Close
, and
John M. Watkins Department of Radiation Oncology, University of Iowa, Iowa City, Iowa, USA

Search for other papers by John M. Watkins in
Google Scholar
PubMed
Close

by dose level The long-term toxicities of RAI include secondary primary malignancy (SPM) [ 51 - 57 ], sialoadenitis [ 58 ], nasolacrimal duct obstruction [ 59 ], and infertility [ 60 ]. The increased risk of primary malignancy in thyroid

Free access
Jan Jiskra 3rd Department of Medicine, 1st Faculty of Medicine, Charles University, General University Hospital, Prague, Czech Republic

Search for other papers by Jan Jiskra in
Google Scholar
PubMed
Close
,
Jiří Horáček 4th Department of Medicine, Faculty of Medicine, Charles University, University Hospital Hradec Králové, Czech Republic

Search for other papers by Jiří Horáček in
Google Scholar
PubMed
Close
,
Sylvie Špitálníková Department of Nuclear Medicine, District Hospital, Havlíčkův Brod, Czech Republic

Search for other papers by Sylvie Špitálníková in
Google Scholar
PubMed
Close
,
Jan Paleček 3rd Department of Medicine, 1st Faculty of Medicine, Charles University, General University Hospital, Prague, Czech Republic

Search for other papers by Jan Paleček in
Google Scholar
PubMed
Close
,
Zdeňka Límanová 3rd Department of Medicine, 1st Faculty of Medicine, Charles University, General University Hospital, Prague, Czech Republic

Search for other papers by Zdeňka Límanová in
Google Scholar
PubMed
Close
,
Jan Krátký 3rd Department of Medicine, 1st Faculty of Medicine, Charles University, General University Hospital, Prague, Czech Republic

Search for other papers by Jan Krátký in
Google Scholar
PubMed
Close
,
Drahomíra Springer Department of Clinical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University, General University Hospital, Prague, Czech Republic

Search for other papers by Drahomíra Springer in
Google Scholar
PubMed
Close
,
Kristýna Žabková 3rd Department of Medicine, 1st Faculty of Medicine, Charles University, General University Hospital, Prague, Czech Republic

Search for other papers by Kristýna Žabková in
Google Scholar
PubMed
Close
, and
Hana Vítková 3rd Department of Medicine, 1st Faculty of Medicine, Charles University, General University Hospital, Prague, Czech Republic

Search for other papers by Hana Vítková in
Google Scholar
PubMed
Close

ultrasound malignancy risk stratification of thyroid nodules in adults: the EU-TIRADS . European Thyroid Journal 2017 6 225 – 237 . ( https://doi.org/10.1159/000478927 ) 15 Haugen BR Alexander EK Bible KC Doherty GM Mandel SJ Nikiforov YE

Open access
Samuel Chan Department of Ear, Nose, and Throat Surgery, St George’s Hospital, London, United Kingdom

Search for other papers by Samuel Chan in
Google Scholar
PubMed
Close
,
Katarina Karamali Department of Ear, Nose, and Throat Surgery, St George’s Hospital, London, United Kingdom

Search for other papers by Katarina Karamali in
Google Scholar
PubMed
Close
,
Anna Kolodziejczyk Department of Ear, Nose, and Throat Surgery, St George’s Hospital, London, United Kingdom

Search for other papers by Anna Kolodziejczyk in
Google Scholar
PubMed
Close
,
Georgios Oikonomou Department of Ear, Nose, and Throat Surgery, St George’s Hospital, London, United Kingdom

Search for other papers by Georgios Oikonomou in
Google Scholar
PubMed
Close
,
John Watkinson Department of Ear, Nose, and Throat Surgery, GOSH, London, United Kingdom

Search for other papers by John Watkinson in
Google Scholar
PubMed
Close
,
Vinidh Paleri The Royal Marsden Hospital, London, United Kingdom

Search for other papers by Vinidh Paleri in
Google Scholar
PubMed
Close
,
Iain Nixon Department of Ear, Nose, and Throat Surgery, NHS Lothian, University of Edinburgh, Edinburgh, United Kingdom

Search for other papers by Iain Nixon in
Google Scholar
PubMed
Close
, and
Dae Kim Department of Ear, Nose, and Throat Surgery, St George’s Hospital, London, United Kingdom

Search for other papers by Dae Kim in
Google Scholar
PubMed
Close

Introduction The incidence of well-differentiated thyroid cancer (DTC) is increasing faster than any other malignancies and estimated to increase by 30% by 2022 [ 1 ]. Most new cases are less than 4-cm tumours (T1–2), often diagnosed early due

Free access
Dorinda Mullen Department of Pathology, St. Vincent’s University Hospital, Dublin 4, Ireland

Search for other papers by Dorinda Mullen in
Google Scholar
PubMed
Close
,
Sarah Mullins Department of Pathology, St. Vincent’s University Hospital, Dublin 4, Ireland

Search for other papers by Sarah Mullins in
Google Scholar
PubMed
Close
,
Aoife Doyle Department of Pathology, St. Vincent’s University Hospital, Dublin 4, Ireland

Search for other papers by Aoife Doyle in
Google Scholar
PubMed
Close
,
Rachel K. Crowley Department of Endocrinology, St. Vincent’s University Hospital, Dublin 4, Ireland
School of Medicine and Medical Sciences, University College Dublin, Dublin 4, Ireland

Search for other papers by Rachel K. Crowley in
Google Scholar
PubMed
Close
,
Stephen Skehan Department of Radiology, St. Vincent’s University Hospital, Dublin 4, Ireland
School of Medicine and Medical Sciences, University College Dublin, Dublin 4, Ireland

Search for other papers by Stephen Skehan in
Google Scholar
PubMed
Close
,
Enda W. McDermott Department of Surgery, St. Vincent’s University Hospital, Dublin 4, Ireland
School of Medicine and Medical Sciences, University College Dublin, Dublin 4, Ireland

Search for other papers by Enda W. McDermott in
Google Scholar
PubMed
Close
,
Ruth S. Prichard Department of Surgery, St. Vincent’s University Hospital, Dublin 4, Ireland
School of Medicine and Medical Sciences, University College Dublin, Dublin 4, Ireland

Search for other papers by Ruth S. Prichard in
Google Scholar
PubMed
Close
, and
David Gibbons Department of Pathology, St. Vincent’s University Hospital, Dublin 4, Ireland
School of Medicine and Medical Sciences, University College Dublin, Dublin 4, Ireland

Search for other papers by David Gibbons in
Google Scholar
PubMed
Close

categories, and so it is not possible to classify with confidence whether a lesion is benign, suspicious for malignancy, or malignant. The clinical management of these lesions is very difficult due to this undetermined risk of malignancy. The introduction

Free access
Mafalda Marcelino Department of Endocrinology, Armed Forces University Hospital, Lisbon, Portugal
Department of Endocrinology, Portuguese Institute of Oncology, Lisbon, Portugal

Search for other papers by Mafalda Marcelino in
Google Scholar
PubMed
Close
,
Pedro Marques Department of Endocrinology, Portuguese Institute of Oncology, Lisbon, Portugal

Search for other papers by Pedro Marques in
Google Scholar
PubMed
Close
,
Luis Lopes Department of Endocrinology, Armed Forces University Hospital, Lisbon, Portugal

Search for other papers by Luis Lopes in
Google Scholar
PubMed
Close
,
Valeriano Leite Department of Endocrinology, Portuguese Institute of Oncology, Lisbon, Portugal

Search for other papers by Valeriano Leite in
Google Scholar
PubMed
Close
, and
João Jácome de Castro Department of Endocrinology, Armed Forces University Hospital, Lisbon, Portugal

Search for other papers by João Jácome de Castro in
Google Scholar
PubMed
Close

significantly higher than usually assumed (3% [ 10 ] vs. 18% [ 11 ]). Cerci et al. [ 12 ] found no significant difference in the incidence of thyroid cancer between TMNG and nontoxic multinodular goiter (MNG). The risk of malignancy in Graves' disease might be

Free access
L.A. Jonker Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands

Search for other papers by L.A. Jonker in
Google Scholar
PubMed
Close
,
C.A. Lebbink Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands

Search for other papers by C.A. Lebbink in
Google Scholar
PubMed
Close
,
M.C.J. Jongmans Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands

Search for other papers by M.C.J. Jongmans in
Google Scholar
PubMed
Close
,
R.A.J. Nievelstein Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Department of Pediatric Radiology and Nuclear Medicine, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands

Search for other papers by R.A.J. Nievelstein in
Google Scholar
PubMed
Close
,
J.H.M. Merks Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands

Search for other papers by J.H.M. Merks in
Google Scholar
PubMed
Close
,
E.J.M. Nieveen van Dijkum Department of Surgery, Cancer Center Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands

Search for other papers by E.J.M. Nieveen van Dijkum in
Google Scholar
PubMed
Close
,
T.P. Links Department of Endocrinology, University Medical Center Groningen, Groningen, The Netherlands

Search for other papers by T.P. Links in
Google Scholar
PubMed
Close
,
N. Hoogerbrugge Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands

Search for other papers by N. Hoogerbrugge in
Google Scholar
PubMed
Close
,
A.S.P. van Trotsenburg Department of Pediatric Endocrinology, Emma Children’s Hospital, Amsterdam University Medical Center, Amsterdam, The Netherlands

Search for other papers by A.S.P. van Trotsenburg in
Google Scholar
PubMed
Close
, and
H.M. van Santen Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands

Search for other papers by H.M. van Santen in
Google Scholar
PubMed
Close

– activity which is undesirable in young patients and in patients at risk for secondary malignancies [ 20 ]. Based on these arguments, the national expert panel recommends surveillance for DTC in children with PHTS to enable detection of DTC in an early

Open access
F. Cecoli Endocrinology, Nuclear Medicine and Autoimmunity Laboratory, Department of Internal Medicine, and Department of Experimental Medicine, Genoa University, and IRCCS Azienda Ospedaliera Universitaria San Martino - IST Genoa

Search for other papers by F. Cecoli in
Google Scholar
PubMed
Close
,
E.M. Ceresola Endocrinology, Nuclear Medicine and Autoimmunity Laboratory, Department of Internal Medicine, and Department of Experimental Medicine, Genoa University, and IRCCS Azienda Ospedaliera Universitaria San Martino - IST Genoa

Search for other papers by E.M. Ceresola in
Google Scholar
PubMed
Close
,
V. Altrinetti Endocrinology and Nuclear Medicine, Galliera Hospital, Genoa

Search for other papers by V. Altrinetti in
Google Scholar
PubMed
Close
,
M. Cabria Endocrinology and Nuclear Medicine, Galliera Hospital, Genoa

Search for other papers by M. Cabria in
Google Scholar
PubMed
Close
,
M. Cappagli Endocrine Unit, Sant'Andrea Hospital, La Spezia

Search for other papers by M. Cappagli in
Google Scholar
PubMed
Close
,
A. Montepagani Endocrine Unit, Sant'Andrea Hospital, La Spezia

Search for other papers by A. Montepagani in
Google Scholar
PubMed
Close
,
C.M. Cuttica Endocrinology and Nuclear Medicine, Galliera Hospital, Genoa

Search for other papers by C.M. Cuttica in
Google Scholar
PubMed
Close
,
U. Filippi Evangelico Internazionale Hospital, Genoa

Search for other papers by U. Filippi in
Google Scholar
PubMed
Close
,
D. Saverino Endocrinology, Nuclear Medicine and Autoimmunity Laboratory, Department of Internal Medicine, and Department of Experimental Medicine, Genoa University, and IRCCS Azienda Ospedaliera Universitaria San Martino - IST Genoa

Search for other papers by D. Saverino in
Google Scholar
PubMed
Close
,
M. Raffa Endocrine-Metabolic Center, ASL 1, Imperia, Italy

Search for other papers by M. Raffa in
Google Scholar
PubMed
Close
,
M. Caputo Endocrinology, Nuclear Medicine and Autoimmunity Laboratory, Department of Internal Medicine, and Department of Experimental Medicine, Genoa University, and IRCCS Azienda Ospedaliera Universitaria San Martino - IST Genoa

Search for other papers by M. Caputo in
Google Scholar
PubMed
Close
,
F. Minuto Endocrinology, Nuclear Medicine and Autoimmunity Laboratory, Department of Internal Medicine, and Department of Experimental Medicine, Genoa University, and IRCCS Azienda Ospedaliera Universitaria San Martino - IST Genoa

Search for other papers by F. Minuto in
Google Scholar
PubMed
Close
,
M. Giusti Endocrinology, Nuclear Medicine and Autoimmunity Laboratory, Department of Internal Medicine, and Department of Experimental Medicine, Genoa University, and IRCCS Azienda Ospedaliera Universitaria San Martino - IST Genoa

Search for other papers by M. Giusti in
Google Scholar
PubMed
Close
, and
M. Bagnasco Endocrinology, Nuclear Medicine and Autoimmunity Laboratory, Department of Internal Medicine, and Department of Experimental Medicine, Genoa University, and IRCCS Azienda Ospedaliera Universitaria San Martino - IST Genoa

Search for other papers by M. Bagnasco in
Google Scholar
PubMed
Close

iodine (RAI), there is agreement that patients with very-low-risk thyroid cancers (≤1 cm confined to the thyroid) do not require RAI. In addition, the TSH goal is a matter of debate [ 18 ]. According to the latest ATA guidelines [ 11 ], in patients free

Free access
Julia A Baran Division of Endocrinology and Diabetes, The Thyroid Center, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

Search for other papers by Julia A Baran in
Google Scholar
PubMed
Close
,
Mya Bojarsky Division of Endocrinology and Diabetes, The Thyroid Center, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

Search for other papers by Mya Bojarsky in
Google Scholar
PubMed
Close
,
Stephen Halada Division of Endocrinology and Diabetes, The Thyroid Center, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

Search for other papers by Stephen Halada in
Google Scholar
PubMed
Close
,
Julio C Ricarte-Filho Division of Endocrinology and Diabetes, The Thyroid Center, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

Search for other papers by Julio C Ricarte-Filho in
Google Scholar
PubMed
Close
,
Amber Isaza Division of Endocrinology and Diabetes, The Thyroid Center, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

Search for other papers by Amber Isaza in
Google Scholar
PubMed
Close
,
Aime T Franco Division of Endocrinology and Diabetes, The Thyroid Center, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

Search for other papers by Aime T Franco in
Google Scholar
PubMed
Close
,
Lea F Surrey Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania, USA

Search for other papers by Lea F Surrey in
Google Scholar
PubMed
Close
,
Tricia Bhatti Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania, USA

Search for other papers by Tricia Bhatti in
Google Scholar
PubMed
Close
,
Zubair Baloch Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania, USA

Search for other papers by Zubair Baloch in
Google Scholar
PubMed
Close
,
N Scott Adzick Department of Surgery, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

Search for other papers by N Scott Adzick in
Google Scholar
PubMed
Close
,
Sogol Mostoufi-Moab Division of Endocrinology and Diabetes, The Thyroid Center, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
Division of Oncology, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

Search for other papers by Sogol Mostoufi-Moab in
Google Scholar
PubMed
Close
,
Ken Kazahaya Division of Pediatric Otolaryngology, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA

Search for other papers by Ken Kazahaya in
Google Scholar
PubMed
Close
, and
Andrew J Bauer Division of Endocrinology and Diabetes, The Thyroid Center, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

Search for other papers by Andrew J Bauer in
Google Scholar
PubMed
Close

data demonstrating a high rate of metastasis (30–90%) ( 6 , 7 ) to regional lymph nodes (LNs) in the pediatric population and was used to stratify patients into ATA risk levels for selective use of radioiodine therapy (RAIT; Recommendation 15) ( 5 , 8

Open access